P3781
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.Vismodegib: in locally advanced or metastatic basal cell carcinoma.Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.Vismodegib.Molecular pathways: the hedgehog signaling pathway in cancer.Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjectsVismodegib in basal cell carcinoma.A single dose mass balance study of the Hedgehog pathway inhibitor vismodegib (GDC-0449) in humans using accelerator mass spectrometry.Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors.Ivacaftor, vismodegib, and ingenol mebutate.Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog PathwayVismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practiceA Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor BiopsyA Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaPhase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaStudy Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell CarcinomaA Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary FibrosisVismodegib granted FDA approval for treatment of basal cell carcinomaVismodegibVismodegib (Erivedge) for basal cell carcinoma
P921
description
Arzneistoff gegen Basalzellkarzinom
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Vismodegib
@de
Vismodegib
@sh
Vismodegib
@sr
vismodegib
@en
vismodégib
@fr
ויסמודגיב
@he
فيزموديجيب
@ar
ビスモデギブ
@ja
type
label
Vismodegib
@de
Vismodegib
@sh
Vismodegib
@sr
vismodegib
@en
vismodégib
@fr
ויסמודגיב
@he
فيزموديجيب
@ar
ビスモデギブ
@ja
altLabel
Erivedge®
@en
GDC-0449
@en
Hedgehog Antagonist GDC-0449
@en
HhAntag691
@en
Vismodegib
@en
Vismodegibum
@en
vismodegib
@fr
prefLabel
Vismodegib
@de
Vismodegib
@sh
Vismodegib
@sr
vismodegib
@en
vismodégib
@fr
ויסמודגיב
@he
فيزموديجيب
@ar
ビスモデギブ
@ja